MLchartDataset catalogue

autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine

Term · Oncology and biomedicine · MLC-T-ONC-011614

A cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-011614
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011614",
  "term": "autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-ebv-transformed-b-lymphoblastoid-tumor-fusion-cell-vaccine/"
}

Record 2,948 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.